May 1, 2009

Norwich Expansion Attracts Top Business Development Leader

Norwich, NY - Norwich Pharmaceuticals, Inc., a perennial leader in contract manufacturing and packaging, has added a top-level veteran of the industry, ensuring the successful management of its expanded services. Dale A. Dyer joined the company as its Director of Business Development.

Dale Dyer has over 25 years of extensive expertise in marketing and sales of contract manufacturing services, and brand and generic pharmaceutical products. "Dale has a demonstrated ability to generate and execute an effective business development strategy from the ground up,” noted Chris Calhoun, president of Norwich Pharmaceuticals. "She will be vital in helping us make the most of our recent specialized equipment investments.”

Dyer most recently held senior positions at Covidien, Tyco Healthcare and Mallinckrodt Inc., including serving as marketing and sales manager for Covidien since 1996. Earlier in her career Dyer received several national sales awards and achieved top honors while at Glaxo/SmithKlineBeecham and Stuart Pharmaceuticals.

"In the past, Norwich limited its scope of services to manufacturing, packaging, and quality control testing support." noted Dyer. "We will now assist customers throughout the life cycle of a product, as well as help plan and launch new initiatives, from simple line extensions to explorations into new product categories.”

According to Calhoun, "Dale Dyer brings a global perspective and a proven ability to plan, develop and implement programs vital to meet present and future industry demands. We expect her to have a significant influence on the success of our clients well into the future.”

Norwich has been steadily gearing up for its current expansion of services with major capital investments in specialized technology and through a selective build-up of key personnel. The company, now serving the pharmaceutical industry for over 100 years, will be actively offering full service product development support from formulation through post-marketing, as well as individual services on an as-needed basis in many specialized areas. "We’re currently in a position to cost effectively trial new products for our customers prior to going to full-scale production,” says company president Chris Calhoun.

Media and Business Inquiries:

Joseph Miller
Director, Marketing and Communications
Norwich Pharmaceuticals, Inc.
6826 State Highway 12
Norwich, NY 13815
Tel: 862-485-0023
Fax: 610-918-8502
E-mail: joe.miller@alvogen.com

Click here to obtain more information.